| Abstrakt: |
A recent study from the University of Chicago explores the advancements and applications of clinical trials in a dish (CTiDs) in the field of bioengineering. The research highlights the role of technologies like induced pluripotent stem cells and organs-on-a-chip in translational research, animal testing, disease modeling, and space radiation technologies. The review also discusses the advantages, disadvantages, regulatory considerations, and challenges of CTiDs, emphasizing their potential in future experimentation. For more information, the full article is available in Bioengineering, published by MDPI AG. [Extracted from the article] |
